Cargando…
A Case of Ocular Benign Lymphoid Hyperplasia Treated with Bevacizumab Injection
We report the first case of ocular benign lymphoid hyperplasia (BLH) treated with subconjunctival injection of bevacizumab (Avastin). A 27-year-old man presented to our clinic with conjunctival masses and limbal neovascularization. An incisional biopsy yielded the diagnosis of BLH. The patient was s...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Ophthalmological Society
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039197/ https://www.ncbi.nlm.nih.gov/pubmed/21350697 http://dx.doi.org/10.3341/kjo.2011.25.1.57 |
_version_ | 1782198172359065600 |
---|---|
author | Oh, Doo Hwan Chun, Yeoun Sook Kim, Jae Chan |
author_facet | Oh, Doo Hwan Chun, Yeoun Sook Kim, Jae Chan |
author_sort | Oh, Doo Hwan |
collection | PubMed |
description | We report the first case of ocular benign lymphoid hyperplasia (BLH) treated with subconjunctival injection of bevacizumab (Avastin). A 27-year-old man presented to our clinic with conjunctival masses and limbal neovascularization. An incisional biopsy yielded the diagnosis of BLH. The patient was subsequently given a subconjunctival injection of bevacizumab (1.25 mg / 0.1 mL). The patient did not experience recurrence or malignant metaplasia during the one-year follow-up period. In patients with conjunctival BLH, subconjunctival injection of bevacizumab can be a useful treatment option in patients unable to undergo a surgical procedure due to limbal neovascularization. |
format | Text |
id | pubmed-3039197 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | The Korean Ophthalmological Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-30391972011-02-24 A Case of Ocular Benign Lymphoid Hyperplasia Treated with Bevacizumab Injection Oh, Doo Hwan Chun, Yeoun Sook Kim, Jae Chan Korean J Ophthalmol Case Report We report the first case of ocular benign lymphoid hyperplasia (BLH) treated with subconjunctival injection of bevacizumab (Avastin). A 27-year-old man presented to our clinic with conjunctival masses and limbal neovascularization. An incisional biopsy yielded the diagnosis of BLH. The patient was subsequently given a subconjunctival injection of bevacizumab (1.25 mg / 0.1 mL). The patient did not experience recurrence or malignant metaplasia during the one-year follow-up period. In patients with conjunctival BLH, subconjunctival injection of bevacizumab can be a useful treatment option in patients unable to undergo a surgical procedure due to limbal neovascularization. The Korean Ophthalmological Society 2011-02 2011-01-17 /pmc/articles/PMC3039197/ /pubmed/21350697 http://dx.doi.org/10.3341/kjo.2011.25.1.57 Text en © 2011 The Korean Ophthalmological Society http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Oh, Doo Hwan Chun, Yeoun Sook Kim, Jae Chan A Case of Ocular Benign Lymphoid Hyperplasia Treated with Bevacizumab Injection |
title | A Case of Ocular Benign Lymphoid Hyperplasia Treated with Bevacizumab Injection |
title_full | A Case of Ocular Benign Lymphoid Hyperplasia Treated with Bevacizumab Injection |
title_fullStr | A Case of Ocular Benign Lymphoid Hyperplasia Treated with Bevacizumab Injection |
title_full_unstemmed | A Case of Ocular Benign Lymphoid Hyperplasia Treated with Bevacizumab Injection |
title_short | A Case of Ocular Benign Lymphoid Hyperplasia Treated with Bevacizumab Injection |
title_sort | case of ocular benign lymphoid hyperplasia treated with bevacizumab injection |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039197/ https://www.ncbi.nlm.nih.gov/pubmed/21350697 http://dx.doi.org/10.3341/kjo.2011.25.1.57 |
work_keys_str_mv | AT ohdoohwan acaseofocularbenignlymphoidhyperplasiatreatedwithbevacizumabinjection AT chunyeounsook acaseofocularbenignlymphoidhyperplasiatreatedwithbevacizumabinjection AT kimjaechan acaseofocularbenignlymphoidhyperplasiatreatedwithbevacizumabinjection AT ohdoohwan caseofocularbenignlymphoidhyperplasiatreatedwithbevacizumabinjection AT chunyeounsook caseofocularbenignlymphoidhyperplasiatreatedwithbevacizumabinjection AT kimjaechan caseofocularbenignlymphoidhyperplasiatreatedwithbevacizumabinjection |